These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

574 related articles for article (PubMed ID: 32126449)

  • 1. Structural basis and designing of peptide vaccine using PE-PGRS family protein of Mycobacterium ulcerans-An integrated vaccinomics approach.
    Nain Z; Karim MM; Sen MK; Adhikari UK
    Mol Immunol; 2020 Apr; 120():146-163. PubMed ID: 32126449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of potential candidate vaccines against
    Ishwarlall TZ; Adeleke VT; Maharaj L; Okpeku M; Adeniyi AA; Adeleke MA
    Front Immunol; 2022; 13():1023558. PubMed ID: 36426350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant BCG Expressing Mycobacterium ulcerans Ag85A Imparts Enhanced Protection against Experimental Buruli ulcer.
    Hart BE; Hale LP; Lee S
    PLoS Negl Trop Dis; 2015 Sep; 9(9):e0004046. PubMed ID: 26393347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-epitope DnaK peptide vaccine against S.Typhi: An in silico approach.
    Verma S; Sugadev R; Kumar A; Chandna S; Ganju L; Bansal A
    Vaccine; 2018 Jun; 36(28):4014-4022. PubMed ID: 29861180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination with the Surface Proteins MUL_2232 and MUL_3720 of Mycobacterium ulcerans Induces Antibodies but Fails to Provide Protection against Buruli Ulcer.
    Bolz M; Bénard A; Dreyer AM; Kerber S; Vettiger A; Oehlmann W; Singh M; Duthie MS; Pluschke G
    PLoS Negl Trop Dis; 2016 Feb; 10(2):e0004431. PubMed ID: 26849213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-epitope vaccine candidates based on mycobacterial membrane protein large (MmpL) proteins against
    Ishwarlall TZ; Adeleke VT; Maharaj L; Okpeku M; Adeniyi AA; Adeleke MA
    Open Biol; 2023 Nov; 13(11):230330. PubMed ID: 37935359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of a Mycobacterium ulcerans Ag85B-EsxH Fusion Protein in Recombinant BCG Improves Experimental Buruli Ulcer Vaccine Efficacy.
    Hart BE; Lee S
    PLoS Negl Trop Dis; 2016 Dec; 10(12):e0005229. PubMed ID: 27941982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reverse vaccinology assisted designing of multiepitope-based subunit vaccine against SARS-CoV-2.
    Tahir Ul Qamar M; Shahid F; Aslam S; Ashfaq UA; Aslam S; Fatima I; Fareed MM; Zohaib A; Chen LL
    Infect Dis Poverty; 2020 Sep; 9(1):132. PubMed ID: 32938504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring T & B-cell epitopes and designing multi-epitope subunit vaccine targeting integration step of HIV-1 lifecycle using immunoinformatics approach.
    Abdulla F; Adhikari UK; Uddin MK
    Microb Pathog; 2019 Dec; 137():103791. PubMed ID: 31606417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A reverse vaccinology and immunoinformatics approach for designing a multiepitope vaccine against SARS-CoV-2.
    Jahangirian E; Jamal GA; Nouroozi M; Mohammadpour A
    Immunogenetics; 2021 Dec; 73(6):459-477. PubMed ID: 34542663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of peptide vaccine candidate using highly antigenic PE-PGRS family proteins to stimulate the host immune response against
    Kumar A; Sharma P; Arun A; Meena LS
    J Biomol Struct Dyn; 2023 May; 41(8):3382-3404. PubMed ID: 35293852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excavating chikungunya genome to design B and T cell multi-epitope subunit vaccine using comprehensive immunoinformatics approach to control chikungunya infection.
    Narula A; Pandey RK; Khatoon N; Mishra A; Prajapati VK
    Infect Genet Evol; 2018 Jul; 61():4-15. PubMed ID: 29535024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a multi-epitope peptide vaccine inducing robust T cell responses against brucellosis using immunoinformatics based approaches.
    Saadi M; Karkhah A; Nouri HR
    Infect Genet Evol; 2017 Jul; 51():227-234. PubMed ID: 28411163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combating tigecycline resistant Acinetobacter baumannii: A leap forward towards multi-epitope based vaccine discovery.
    Ahmad S; Ranaghan KE; Azam SS
    Eur J Pharm Sci; 2019 Apr; 132():1-17. PubMed ID: 30797936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of Recombinant Virus Replicon Particles for Vaccination against Mycobacterium ulcerans Disease.
    Bolz M; Kerber S; Zimmer G; Pluschke G
    PLoS Negl Trop Dis; 2015; 9(8):e0004011. PubMed ID: 26275222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3CL hydrolase-based multiepitope peptide vaccine against SARS-CoV-2 using immunoinformatics.
    Jakhar R; Kaushik S; Gakhar SK
    J Med Virol; 2020 Oct; 92(10):2114-2123. PubMed ID: 32379348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Designing an efficient multi-epitope oral vaccine against Helicobacter pylori using immunoinformatics and structural vaccinology approaches.
    Nezafat N; Eslami M; Negahdaripour M; Rahbar MR; Ghasemi Y
    Mol Biosyst; 2017 Mar; 13(4):699-713. PubMed ID: 28194462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multi-subunit based, thermodynamically stable model vaccine using combined immunoinformatics and protein structure based approach.
    Rana A; Akhter Y
    Immunobiology; 2016 Apr; 221(4):544-57. PubMed ID: 26707618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In silico design of a vaccine candidate based on autotransporters and HSP against the causal agent of shigellosis, Shigella flexneri.
    León Y; Zapata L; Salas-Burgos A; Oñate A
    Mol Immunol; 2020 May; 121():47-58. PubMed ID: 32163758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Buruli ulcer.
    Einarsdottir T; Huygen K
    Hum Vaccin; 2011 Nov; 7(11):1198-203. PubMed ID: 22048117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.